Skip to main content
. 2022 Jan 17;32(1):28–36. doi: 10.1089/thy.2021.0356

Table 1.

Clinical and Pathological Characteristics of the Entire Cohort

  All patients (n = 3756), n (%) Lobectomy (n = 943), n (%) Total thyroidectomy (n = 2813), n (%) p
Age, years        
 <55 2455 (65) 683 (72) 1772 (63) <0.0001
 ≥55 1301 (35) 260 (28) 1041 (37)
Sex
 Female 2894 (77) 685 (73) 2209 (79) 0.0002
 Male 862 (23) 258 (27) 604 (21)
Pathology
 Papillary 3606 (96) 879 (93) 2727 (97) <0.0001
 Follicular 81 (2) 41 (4) 40 (1)
 Hurthle cell 69 (2) 23 (2) 46 (2)
Papillary subgroups
 Tall cell 277 (7) 43 (5) 234 (8) <0.0001
 Occult sclerosing variant 113 (3) 31 (3) 82 (3)
 Classical 1089 (29) 200 (21) 889 (32)
 Columnar 7 (0) 0 (0) 7 (0)
 Solid/trabecular 17 (0) 2 (0) 15 (1)
 Follicular 1074 (29) 343 (36) 731 (26)
 Others 19 (1) 5 (1) 14 (0)
 Unknown 1010 (27) 255 (27) 755 (27)
ATA risk stratification
 Intermediate risk 1091 (29) 215 (23) 876 (31) <0.0001
 Low risk 2665 (71) 728 (77) 1937 (69)
pT stagea
 T1a 1723 (46) 413 (44) 1310 (47) 0.0135
 T1b 1277 (34) 309 (33) 968 (34)
 T2 756 (20) 221 (23) 535 (19)
Multifocality
 Yes 1677 (45) 244 (26) 1433 (51) <0.0001
 No 1948 (52) 614 (65) 1334 (47)
 Unknown 131 (3) 85 (9) 46 (2)
Vascular invasion
 Yes 292 (8) 59 (6) 233 (8) <0.0001
 No 3239 (86) 757 (80) 2482 (88)
 Unknown 225 (6) 127 (14) 98 (4)
Microscopic ETE
 Yes 531 (14) 84 (9) 447 (16) <0.0001
 No 3224 (86) 858 (91) 2366 (84)
 Unknown 1 (0) 1 (0) 0 (0)
Positive margins
 Yes 136 (4) 19 (2) 117 (4) <0.0001
 No 3420 (91) 793 (84) 2627 (93)
 Unknown 200 (5) 131 (14) 69 (3)
a

According to the American Joint Committee Cancer, Eighth edition.

ATA, American Thyroid Association; ETE, extrathyroidal extension; pT, pathological tumor.